Skip to main content

Table 1 Distribution of study population based on Rome III classification

From: Re-investigation of functional gastrointestinal disorders utilizing a machine learning approach

Disorder

Overlapped Samples

Pure samples

Disorder

Overlapped Samples

Pure Samples

Number (%)

Number (%)

Number (%)

Number (%)

FHB

1000

(26.6)

78

(2.1)

FC

618

(16.4)

88

(2.3)

FCP

732

(19.4)

85

(2.3)

FB

725

(19.3)

180

(4.8)

G

269

(7.1)

18

(.5)

FDI

12

(0.3)

3

(0.1)

FDG

290

(7.7)

19

(0.5)

FFI

140

(3.7)

7

(0.2)

FDP

672

(17.8)

28

(0.7)

FDF

484

(12.9)

0

(0)

PF

521

(14)

26

(0.7)

IBS

948

(25.2)

40

(1.1)

EP

354

(9.4)

7

(0.2)

IBS-C

251

(8.9)

2

(0.1)

B

2137

(56.8)

351

(9.3)

IBS-D

151

(6)

5

(0)

V

938

(24.9)

45

(1.2)

IBS-M

126

(4.9)

3

(0.1)

RS

12

(0.3)

0

(0)

IBS-U

198

(6.9)

12

(0.1)

  1. Overlapped samples refer to the population with more than one FGID, and pure samples contain individuals with only one FGID
  2. FHB indicates functional heartburn, FCP Functional chest pain, G Globus, FDG Functional dysphagia, FDP Functional dyspepsia, PF Postprandial fullness, ES Epigastric pain syndrome, B Belching, V Vomiting, RS Rumination syndrome, FC Functional constipation, FB Functional bloating, FDI Functional diarrhea, FFI Functional fecal incontinence, FDF Functional defecation disorder, IBS Irritable bowel syndrome, IBS-C Constipation predominant IBS, IBS-D Diarrhea predominant IBS, IBS-M Mixed-type IBS, and IBS-U Unclassified IBS